Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Supply Agreement with Revolymer®  
11/9/2011 7:27:41 AM

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI), a global contract services organization with services spanning the entire R&D continuum, announced today that it has entered into an agreement with Revolymer®, a technology development company located in the United Kingdom, to become its primary manufacturer and supplier of Rev7™, AGC and other polymers, main components of the company’s revolutionary Rev7™ degradable gum products.